Early bird registration is open and closes May 2025. Register now
Synopsis: Treatment of rheumatoid arthritis has dramatically changed by the appearance of molecular target drugs, and the treatment option with JAK inhibitors had a large
Synopsis: Despite the implementation of the treat-to-target approach and recent advancements in biological therapy of rheumatoid arthritis there are still unmet needs that have to
Agenda: 08:30-08:31 Welcome Remarks: Introduction Chairperson: Prof. Yoshiya Tanaka 08:35-09:15 Adalimumab: A cornerstone in Rheumatology Prof. Josef Smolen
Synopsis: We aim to discuss the challenges in managing patients with MAS related to Still’s disease and to explore future strategies to improve patient care.
Agenda: Chairperson: Prof. Tatsuya Atsumi 11:10-11:15 Welcome & Introduction 11:15-11:30 Part I – Artificial Intelligence Towards an Al-improved patient pathway in RA? Prof. Laurent Arnaud
Agenda: 08:30-08:31 Welcome Remarks: Introduction Chairperson: Prof Kunihiro Yamaoka 08:31-08:52 Optimizing Rheumatoid Arthritis Care in the Elderly： Advantages of Abatacept Yoon-Kyoung, Sung 08:52-09:15 Management of
